Irving GA - Search Results

1

A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

Irving GA, Backonja MM, Dunteman E, Blonsky ER, Vanhove GF, Lu SP, Tobias J; NGX-4010 C117 Study Group. Irving GA, et al. Pain Med. 2011 Jan;12(1):99-109. doi: 10.1111/j.1526-4637.2010.01004.x. Epub 2010 Nov 18. Pain Med. 2011. PMID: 21087403 Clinical Trial.

2

Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.

Jensen MP, Irving G, Rauck R, Wallace M, Sweeney M, Vanhove GF. Jensen MP, et al. Clin J Pain. 2013 Sep;29(9):770-4. doi: 10.1097/AJP.0b013e31827b32ab. Clin J Pain. 2013. PMID: 23370075 Clinical Trial.

3

Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

Rauck RL, Irving GA, Wallace MS, Vanhove GF, Sweeney M. Rauck RL, et al. Among authors: irving ga. J Pain Symptom Manage. 2013 Aug;46(2):219-28. doi: 10.1016/j.jpainsymman.2012.07.011. Epub 2012 Nov 11. J Pain Symptom Manage. 2013. PMID: 23149085 Free article. Clinical Trial.

4

Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.

Irving G, Jensen M, Cramer M, Wu J, Chiang YK, Tark M, Wallace M. Irving G, et al. Clin J Pain. 2009 Mar-Apr;25(3):185-92. doi: 10.1097/AJP.0b013e3181934276. Clin J Pain. 2009. PMID: 19333167 Clinical Trial.

5

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.

Webster L, Jansen JP, Peppin J, Lasko B, Irving G, Morlion B, Snidow J, Pierce A, Mortensen E, Kleoudis C, Carter E. Webster L, et al. Pain. 2008 Jul 15;137(2):428-440. doi: 10.1016/j.pain.2007.11.008. Epub 2007 Dec 31. Pain. 2008. PMID: 18164818 Clinical Trial.

6

A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.

Irving G, Pénzes J, Ramjattan B, Cousins M, Rauck R, Spierings EL, Kleoudis CS, Snidow JW, Pierce A, Wurzelmann J, Mortensen ER. Irving G, et al. J Pain. 2011 Feb;12(2):175-84. doi: 10.1016/j.jpain.2010.06.013. J Pain. 2011. PMID: 21292168 Free article. Clinical Trial.

7

Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.

Wallace MS, Irving G, Cowles VE. Wallace MS, et al. Clin Drug Investig. 2010;30(11):765-76. doi: 10.2165/11539520-000000000-00000. Clin Drug Investig. 2010. PMID: 20818838 Clinical Trial.

8

Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia.

Irving GA, Sweeney M. Irving GA, et al. J Pain Res. 2012;5:203-8. doi: 10.2147/JPR.S32562. Epub 2012 Jun 25. J Pain Res. 2012. PMID: 22792006 Free PMC article.

9

Once-daily gastroretentive gabapentin for treatment of postherpetic neuralgia.

Irving G. Irving G. Pain Manag. 2012 May;2(3):259-65. doi: 10.2217/pmt.12.20. Pain Manag. 2012. PMID: 24654668

10

The placebo response: relationship to outcomes in trials of postherpetic neuralgia.

Irving G. Irving G. Clin Drug Investig. 2010;30(11):739-48. doi: 10.2165/11584300-000000000-00000. Clin Drug Investig. 2010. PMID: 20818836 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page